Combining HIFU With RF, Injectables and Skincare
A HIFU combination treatment is a calendar, not a shopping list. The order you run things in, and the gaps you leave between them, decide whether each step protects the last or quietly undoes it. This is a planning guide for the person who owns the equipment, not a clinical protocol.
Sequencing beats stacking
Stacking is what happens when a clinic buys a second platform and runs both over the same face in the same hour, because the client bought a package. Sequencing is the grown-up version. Same client, same year, different days, in an order somebody can defend out loud.
The difference costs you nothing.
Your machines are already paid for. What you can still change for free is the plan around them: what goes first, how wide the gap is, what the client does at home. Plenty of disappointing results are calendar failures, not device failures.
Where each tool actually lands
Start with the tissue. That is what makes a sequencing rule sensible instead of superstitious.
HIFU treats at depths the cartridge decides, never the power dial. Our HF-01 4D HIFU platform runs 4-7MHz, with 3.0mm and 4.5mm cartridges on the 4D handle, 1.5mm, 3.0mm and 4.5mm on the V-max handle, and body cartridges out to 16mm. The 4.5mm setting is the one aimed at the SMAS.
Radiofrequency does the opposite of focusing. Our device manuals describe RF as a high-frequency electromagnetic wave that heats through tissue resistance and drives dermal cells to roughly 45°C to 60°C, where collagen starts to respond, applied with gel and a handpiece kept moving so the client is not burned. Our RF-01 skin tightening platform is bipolar, and its specification sheet gives the working range as epidermis, dermis and the upper subcutaneous layer, about 5mm down. Our archive explains why bipolar stops around there: penetration runs to roughly half the gap between the poles, and both poles sit in one handpiece.
Set that against the anatomy in our skin anatomy training deck. Epidermis about 0.1 to 0.4mm. Dermis about 0.5 to 4mm. Subcutaneous tissue underneath.
Do that arithmetic and a comfortable sales line falls over. A 4.5mm HIFU focus is not sitting safely below RF territory. It sits at the deep edge of that RF volume, or just inside it.
What separates them is not where they reach. It is how the energy arrives, and how much lands per unit of tissue. RF warms a volume through, and our training material describes that heat as columns distributed across the treated tissue. HIFU converges sound to a point and leaves discrete coagulation zones, twelve lines per shot, with our manuals putting the SMAS focus at 60°C to 70°C. Broad and warm against small and hot. Not interchangeable doses, even where the volumes coincide.
Injectables bring a third geometry. Product sits in planes a prescriber chose deliberately, and some of those planes are exactly where your energy is going. That is what turns an interval into a clinical question rather than a habit.
What the published record actually supports
Read the table as a scheduling aid, not permission. Every injectable row needs the prescriber's sign-off first.
| Combination | What the record shows | What it means for your diary |
|---|---|---|
| HIFU, then hyaluronic acid filler, same visit | A pan-Asian expert adaptation places microfocused ultrasound before fillers in a single session, and reports energy delivered over injected hyaluronic acid or calcium hydroxylapatite did not change filler appearance, raise inflammation or cause migration | If both happen in one visit, book the device slot first and the injector second |
| HIFU over filler already in place | Vachiramon and colleagues treated injected sites at 60 minutes, day 14 and day 28. Mean filler grading fell significantly at the 60-minute and day-14 sites by day 56; the day-28 site showed no statistically significant loss, and no inflammation or granuloma was seen | Recent filler in the treatment field is a reason to move the HIFU date, not a reason to push through |
| HIFU or monopolar RF alongside neuromodulators and fillers, long term | A retrospective review of 1,040 patients treated over 18 years with microfocused ultrasound or monopolar radiofrequency alongside cosmetic injectables reported no infection, necrosis, burn, filler migration or unexpected premature filler loss | Combination programmes are ordinary practice; document them like ordinary practice |
| Toxin cycles around a device course | The FDA label for onabotulinumtoxinA cosmetic gives a duration of effect for glabellar lines of about three to four months, and states dosing more often than every three months has not been clinically evaluated | Toxin has its own clock. Fit the device dates around it rather than the reverse |
Filler: why practitioners separate the field
Nobody serious claims ultrasound melts filler on contact. The real issue is subtler: heat delivered into a plane holding fresh product can shorten how long the client keeps what they paid for, and swelling from a recent injection makes the field harder to read.
The clinicopathological study above is the clearest picture published so far. Filler intradermally, energy at three different intervals. Loss showed up where the gap was short, and stopped being statistically significant at the four-week site.
So when a distributor calls HIFU and filler "completely compatible", the honest version is longer. They coexist well. Timing still matters, and the rule most practitioners follow, energy first then injection, exists because you cannot glide and press a freshly injected face without moving product.
Who decides? The prescriber. Not you, not your operator, and not the client with a wedding in nine days.
Toxin timing is a conversation in weeks
Toxin behaves nothing like filler here. There is no bolus of material sitting in a plane to displace. What you get instead is a slow onset and a defined cycle, which is why practitioners talk about the gap in weeks and why re-dosing intervals sit in months on the label rather than in how the client feels.
Two consequences for an equipment owner. A client mid-cycle is not at baseline, so photographs taken that day make a poor before-shot. And an assessment made days after injection reads a moving target.
The consensus material gives the intuitive order on the upper face: tighten with the device, relax the depressors with toxin, restore volume where it has gone. Your job is to make the booking system reflect a decision the prescriber already made, in writing, with dates. Keep it that way when the client pushes.
RF and HIFU: same client, separate days
The two treatment volumes overlap around the 4.5 to 5mm mark. So the useful question was never which device wins. It is how much heat one face should absorb in an afternoon, and who gets what, when.
The commercial pattern is simple. HIFU is the event, reviewed months later once remodelling has happened. RF is the relationship: a course, then maintenance, priced to bring people back. Selling both on one afternoon compresses two revenue lines into a single appointment and hands the tissue a combined thermal load that neither manual gives you a setting for.
There is a safety argument too, the boring one that matters. Our RF instructions require the handpiece to stay in full contact and always moving, each pass repeated three to five times. That is an operator-attention task. Run it at the end of a long focused-ultrasound session, on a tired technician, and quality drops where it costs you. If something goes wrong on a combined day, you cannot tell which device did it.
Split the days. Write down which platform did what. Our other equipment buying and operations guides cover the pricing and cartridge economics behind that split.
The part that moves the visible result more than a third machine
Here is the uncomfortable part. Devices remodel what is already damaged. They do not switch off the thing doing the damage.
Our photoaging training material describes what chronic sun exposure does underneath: dermal collagen loss with abnormal clumping of elastic fibres, a thinning epidermis with flattened rete ridges, vessel proliferation and chronic inflammation. Clinically that reads as roughness, laxity, sagging, wrinkles and pigmentary change. A client who returns to unprotected daily exposure is refilling that bucket while you empty it.
The American Academy of Dermatology's guidance is unglamorous and cheap to hand out: broad-spectrum sunscreen, SPF 30 or higher, water resistant, reapplied roughly every two hours outdoors, plus shade and clothing. Put it in the plan as a line item, with a product the client leaves holding.
Pigment risk deserves its own line. Our clinical atlas material lists post-inflammatory hyperpigmentation among the complications of energy-based treatment, gives pre-treatment sun protection as prevention, and says to lengthen the interval between sessions when pigmentation appears rather than press on. Darker phototypes carry more of this risk, and our pigmentation grading material warns that at heavier grades, inflammation or trauma leaves deposits that resolve slowly. Anything resembling a diagnosis goes to a clinician first.
Write the plan down, then sell it
A combination programme that lives only in a consultation conversation is not a programme. Put these on paper for every client running more than one modality:
- The sequence, by date, with the reason for each gap beside it
- Which planes have been injected, by whom, and when
- The name of the prescriber who signed off any interval touching an injectable
- Separate consent per modality, not one blanket signature for "a package"
- Which platform treated which zone on which day, so an adverse event has an address
- The home care and sun protection commitment, dated and reviewed
- Your consumable cost per session, so the programme is priced on what it consumes
If a combination plan cannot survive being written down with dates on it, it was a sales pitch, not a treatment plan.
None of this needs a new machine. It needs a diary, a form, and someone senior enough to tell a client who wants everything this week that it is not on offer.
Evidence and further reading
Educational material for equipment buyers and operators. It is not medical advice, an operating protocol or a promise of clinical outcome.
- Park JY, et al. Customized Treatment Using Microfocused Ultrasound with Visualization for Optimized Patient Outcomes: A Review of Skin-tightening Energy Technologies and a Pan-Asian Adaptation of the Expert Panel's Gold Standard Consensus. J Clin Aesthet Dermatol. 2021;14(5):E70-E79 (MFU-V precedes fillers in same-session treatment; MFU energy over hyaluronic acid and calcium hydroxylapatite does not change filler appearance, increase inflammation or induce migration)
- Vachiramon V, Rutnin S, Patcharapojanart C, Chittasirinuvat N. The effect of combined hyaluronic acid dermal filler and microfocused ultrasound treatment: A clinicopathological study. J Cosmet Dermatol. 2023;22(3):792-797 (filler loss at day 56 where MFU followed injection at 60 minutes or day 14; no significant loss at the day-28 site; no inflammation or granuloma)
- Suh DH, Chen LC, Chung HJ, Lee SJ, Kim J. An 18-year comprehensive safety study on microfocused ultrasound and monopolar radiofrequency combined with cosmetic injectables in 1,040 patients. Arch Dermatol Res. 2025;317(1):251 (retrospective chart review, June 2005 to December 2023; no infection, necrosis, burn, filler migration or unexpected premature filler loss reported)
- BOTOX Cosmetic (onabotulinumtoxinA) for injection, US FDA-approved prescribing information, 2024 (duration of effect for glabellar lines approximately 3-4 months; safety and effectiveness of dosing more frequently than every 3 months not clinically evaluated)
- American Academy of Dermatology. Sunscreen FAQs (broad-spectrum, SPF 30 or higher, water resistant, reapply approximately every two hours outdoors, combined with shade and protective clothing)
- Casabona G, Pereira G. Microfocused Ultrasound with Visualization and Calcium Hydroxylapatite for Improving Skin Laxity and Cellulite Appearance. Plast Reconstr Surg Glob Open. 2017;5(7):e1388 (single-session microfocused ultrasound immediately followed by subdermal diluted filler)
- Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524-527
Keep reading
Ready to spec your next machine?
Tell us the indication, your market and the certifications you need. Our export team replies with a configuration and quotation within 12 to 24 hours.